Clean Science & Technology Ltd
Clean Science & Technology Q2 Results 2026 (FY27) investor presentation: Revenue & Margins
Q2 FY27 investor presentation: what the company reported on revenue, margins and capex.
Guidance rank: #52 of 71 in Chemicals & Petrochemicals
See the sector's top 10 — free with your mobile number.
Clean Science & Technology Ltd Q2 FY27 key numbers
- Revenue
- Q2 FY2027 consolidated sales of products: INR 295 crore, up 23% YoY (Q2 FY2026 sales: INR 240 crore).
As stated in Clean Science & Technology Ltd's Q2 FY27 investor presentation · published 31 Oct 2026. Reported figures, not investment advice.
Based on Clean Science & Technology Ltd's Q2 FY27 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.
The short version
Q2 FY2027 consolidated sales of products: INR 295 crore, up 23% YoY (Q2 FY2026 sales: INR 240 crore) - Q2 FY2027 standalone sales of products: INR 226 crore, up 10% YoY (Q2 FY2026 sales: INR 206 crore) - Q2 FY2027 consolidated total revenue: INR 299 crore, up 22% YoY (Q2 FY2026: INR 245 crore) - Q2 FY2027 standalone total revenue: INR 233 crore, up 10% YoY (Q2 FY2026: INR 211 crore) - H1 FY2027 consolidated sales of products: INR 559 crore, up 17% YoY (H1 FY2026: INR 480 crore) - H1 FY2027 standalone sales of products: INR 430 crore, up 2% YoY (H1 FY2026: INR 423 crore) - H1 FY2027 consolidated total revenue: INR 568 crore, up 16% YoY (H1 FY2026: INR 488 crore) - H1 FY2027 standalone total revenue: INR 440 crore, up 2% YoY (H1 FY2026: INR 431 crore) - Outlook: HALS segment grew 2x in H1 FY27; commercial launch of advanced HALS expected in H2 FY27; Performance Chemical 2 expected to commercialize in H2 FY27. Q2 FY2027 Consolidated EBITDA: INR 92 crore, up 5% YoY - Q2 FY2027 Consolidated EBITDA margin: 31.2% (down from 36.4% YoY) - Q2 FY2027 Consolidated Profit after Tax (PAT): INR 56 crore, flat YoY
From Clean Science & Technology Ltd's Q2 FY27 earnings-call transcript · updated 31 Oct 2026.
Revenue & Sales Performance
- Q2 FY2027 consolidated sales of products: INR 295 crore, up 23% YoY (Q2 FY2026 sales: INR 240 crore)
- Q2 FY2027 standalone sales of products: INR 226 crore, up 10% YoY (Q2 FY2026 sales: INR 206 crore)
- Q2 FY2027 consolidated total revenue: INR 299 crore, up 22% YoY (Q2 FY2026: INR 245 crore)
- Q2 FY2027 standalone total revenue: INR 233 crore, up 10% YoY (Q2 FY2026: INR 211 crore)
- H1 FY2027 consolidated sales of products: INR 559 crore, up 17% YoY (H1 FY2026: INR 480 crore)
- H1 FY2027 standalone sales of products: INR 430 crore, up 2% YoY (H1 FY2026: INR 423 crore)
- H1 FY2027 consolidated total revenue: INR 568 crore, up 16% YoY (H1 FY2026: INR 488 crore)
- H1 FY2027 standalone total revenue: INR 440 crore, up 2% YoY (H1 FY2026: INR 431 crore)
2 more points from Clean Science & Technology Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Clean Science & Technology Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Significant greenfield CAPEX planned for commercializing a new series of products (Page 22).
- Advanced HALS product trials completed at Clean Fino Chem Ltd. (CFCL), with commercial launch expected in H2 FY2026-27 (Page 5).
- CFCL wholly owned subsidiary; incurred ~INR 150 crore capex during H1 FY2027 for investment in CFCL (Page 5).
- Largest facility for HALS commercialized at CFCL in March 2024; located in Kurkumbh Industrial Area, Maharashtra; 34 acres site, benefits from tax incentives (Page 20).
- Performance Chemical 2 expected to be commercialized in H2 FY2027 (Page 5).
2 more points from Clean Science & Technology Ltd's call on capex
Create a free account to keep reading this call
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Clean Science & Technology Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
See what Clean Science & Technology Ltd said on order book & pipeline — free account, 30 seconds.
Clean Science & Technology Ltd — Quarterly revenue & net profit
Q2 FY27 figures are not in this chart yet. Latest shown: Jun 2026 (Q1 FY27). The Q2 FY27 numbers from the filing are in the analysis on this page.
Reported quarterly figures (₹ Cr). Latest (Q1 FY27): revenue ₹268 Cr, net profit ₹73 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Clean Science & Technology Ltd's management said in earlier quarters
- Q4 FY25 earnings call analysis →
- Q3 FY26 earnings call analysis →
- Q1 FY27 earnings call analysis →
- Q2 FY26 earnings call analysis →
- Q1 FY26 earnings call →
- Q3 FY25 earnings call →
- Q2 FY25 earnings call →
- Q1 FY25 earnings call →
- Q4 FY24 earnings call →
- Q3 FY24 earnings call →
- Q2 FY24 earnings call →
- Q1 FY24 earnings call →
Others in Chemicals & Petrochemicals this season
- Aarti Industries Ltd (Q2 FY27)
Revenue from Operations (Net) for the quarter ended 30th Sep 2026 (Consolidated): ₹3,668 Cr (Page 3) . Key results statement takeaways from Aarti Industries Ltd
- Chembond Material Technologies Ltd (Q2 FY27)
61% increase) . Key results statement takeaways from Chembond Material Technologies Ltd's Q2 FY27 results statement — and how it ranks against sector peers.
- DMCC Speciality Chemicals Ltd (Q2 FY27)
12,603.12 lakhs for the quarter ended 30th September 2025, representing a year-on-year increase of approximately 116.5%. Key results statement takeaways from DM
- Vinati Organics Ltd (Q2 FY27)
680.21 crores, up from Rs. Key results statement takeaways from Vinati Organics Ltd's Q2 FY27 results statement — and how it ranks against sector peers.
Potential multibaggers · Q2 FY27
Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Clean Science & Technology Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Clean Science & Technology Ltd Q2 FY27 results?
Q2 FY2027 consolidated sales of products: INR 295 crore, up 23% YoY (Q2 FY2026 sales: INR 240 crore) - Q2 FY2027 standalone sales of products: INR 226 crore, up 10% YoY (Q2 FY2026 sales: INR 206 crore) - Q2 FY2027 consolidated total revenue: INR 299 crore, up 22% YoY (Q2 FY2026: INR 245 crore) - Q2 FY2027 standalone total revenue: INR 233 crore, up 10% YoY (Q2 FY2026: INR 211 crore) - H1 FY2027 consolidated sales of products: INR 559 crore, up 17% YoY (H1 FY2026: INR 480 crore) - H1 FY2027 standalone sales of products: INR 430 crore, up 2% YoY (H1 FY2026: INR 423 crore) - H1 FY2027 consolidated total revenue: INR 568 crore, up 16% YoY (H1 FY2026: INR 488 crore) - H1 FY2027 standalone total revenue: INR 440 crore, up 2% YoY (H1 FY2026: INR 431 crore) - Outlook: HALS segment grew 2x in H1 FY27; commercial launch of advanced HALS expected in H2 FY27; Performance Chemical 2 expected to commercialize in H2 FY27. Q2 FY2027 Consolidated EBITDA: INR 92 crore, up 5% YoY - Q2 FY2027 Consolidated EBITDA margin: 31.2% (down from 36.4% YoY) - Q2 FY2027 Consolidated Profit after Tax (PAT): INR 56 crore, flat YoY
What is Clean Science & Technology Ltd share price analysis?
Clean Science & Technology Ltd currently shows a neutral. The stock trades at a P/E of 32.6 with a market cap of ₹7,604 Cr. Investors should review the full earnings analysis for detailed insights.
Is Clean Science & Technology Ltd planning capital expenditure?
Significant greenfield CAPEX planned for commercializing a new series of products (Page 22). - Advanced HALS product trials completed at Clean Fino Chem Ltd.
Keep Clean Science & Technology Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
